Skip to content

PHARMARO: what changed

BE 0899.156.742NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€160,527
2024 · €146,415+€14,113
Equity
€139,852
2024 · €148,024-€8,172
Cash
€195,633
2024 · €253,549-€57,917
Balance sheet total
€493,235
2024 · €527,023-€33,788

Largest movements

2024 to 2025
Assets
  • Cash -€57,917

    down €57,917 (-22.8%), from €253,549 to €195,633

    mainly Contributions, distributions and other (-€168,699) and Other debts (-€42,643)

  • Receivables within one year +€17,154

    up €17,154 (+16.2%), from €106,058 to €123,212

    of which Trade receivables: +€12,581

  • Stocks and contracts +€6,674

    up €6,674 (+5.0%), from €133,178 to €139,851

Equity and liabilities
  • Other debts -€42,643

    down €42,643 (-20.5%), from €207,726 to €165,083

  • Reserves -€8,172

    down €8,172 (-29.6%), from €27,637 to €19,465

  • Trade debts +€7,886

    up €7,886 (+5.1%), from €154,981 to €162,867

  • Provisions +€6,488

    first reported in 2025, at €6,488

Income statement
  • Gross operating margin +€24,802

    up €24,802 (+8.7%), from €286,626 to €311,427

  • Taxes +€5,201

    up €5,201 (+10.5%), from €49,439 to €54,640

  • Staff costs +€4,635

    up €4,635 (+4.9%), from €93,789 to €98,424

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €146,415
Gross operating margin +€24,802
Staff costs -€4,635
Depreciation +€160
Other operating charges -€118
Financial income -€919
Financial charges +€24
Taxes -€5,201
Result 2025 €160,527
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€112,878
Investment -€2,095
Financing -€168,699
Cash 2024 €253,549
Net result for the year +€160,527
Depreciation +€2,383
Stocks and contracts -€6,674
Receivables within one year -€17,154
Deferred charges and accrued income -€589
Provisions +€6,488
Trade debts +€7,886
Tax, wage and social debts +€2,653
Other debts -€42,643
Investment in fixed assets (net) -€2,095
Contributions, distributions and other -€168,699
Cash 2025 €195,633
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €527,023 €493,235 -€33,788 -6.4%
Fixed assets 21/28 €10,658 €10,370 -€288 -2.7%
Tangible fixed assets 22/27 €10,658 €10,370 -€288 -2.7%
Plant, machinery and equipment 23 €237 €55 -€182 -76.7%
Furniture and vehicles 24 €3,037 €2,381 -€656 -21.6%
Other tangible fixed assets 26 €7,384 €7,934 +€550 +7.4%
Current assets 29/58 €516,365 €482,865 -€33,500 -6.5%
Stocks and contracts in progress 3 €133,178 €139,851 +€6,674 +5.0%
Stocks 30/36 €133,178 €139,851 +€6,674 +5.0%
Amounts receivable within one year 40/41 €106,058 €123,212 +€17,154 +16.2%
Trade receivables 40 €106,058 €118,639 +€12,581 +11.9%
Other amounts receivable 41 - €4,573 +€4,573
Current investments 50/53 €20,499 €20,499 = 0.0%
Cash at bank and in hand 54/58 €253,549 €195,633 -€57,917 -22.8%
Deferred charges and accrued income 490/1 €3,082 €3,670 +€589 +19.1%
Total equity and liabilities 10/49 €527,023 €493,235 -€33,788 -6.4%
Equity 10/15 €148,024 €139,852 -€8,172 -5.5%
Contributions 10/11 €120,387 €120,387 = 0.0%
Reserves 13 €27,637 €19,465 -€8,172 -29.6%
Tax-exempt reserves 132 €27,637 €19,465 -€8,172 -29.6%
Provisions and deferred taxes 16 - €6,488 +€6,488
Deferred taxes 168 - €6,488 +€6,488
Amounts payable 17/49 €378,999 €346,895 -€32,104 -8.5%
Amounts payable within one year 42/48 €378,999 €346,895 -€32,104 -8.5%
Trade debts 44 €154,981 €162,867 +€7,886 +5.1%
Suppliers 440/4 €154,981 €162,867 +€7,886 +5.1%
Taxes, remuneration and social security 45 €16,291 €18,944 +€2,653 +16.3%
Taxes 450/3 €3,748 €4,155 +€407 +10.8%
Remuneration and social security 454/9 €12,543 €14,790 +€2,246 +17.9%
Other amounts payable 47/48 €207,726 €165,083 -€42,643 -20.5%
Remuneration, social security and pensions 62 €93,789 €98,424 +€4,635 +4.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,543 €2,383 -€160 -6.3%
Other operating charges 640/8 - €118 +€118
Gross operating margin 9900 €286,626 €311,427 +€24,802 +8.7%
Operating profit (loss) 9901 €190,294 €210,502 +€20,208 +10.6%
Financial income 75/76B €5,346 €4,427 -€919 -17.2%
Recurring financial income 75 €5,346 €4,427 -€919 -17.2%
Financial charges 65/66B €207 €183 -€24 -11.8%
Recurring financial charges 65 €207 €183 -€24 -11.8%
Profit (loss) for the period before taxes 9903 €195,433 €214,746 +€19,313 +9.9%
Transfer from deferred taxes 780 €421 €421 = 0.0%
Income taxes 67/77 €49,439 €54,640 +€5,201 +10.5%
Profit (loss) for the period 9904 €146,415 €160,527 +€14,113 +9.6%
Transfer from tax-exempt reserves 789 €1,263 €1,263 = 0.0%
Profit (loss) for the period to be appropriated 9905 €147,678 €161,790 +€14,113 +9.6%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€593,062 to €802,316

Midpoint €680,251 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €139,852
Capitalised earnings €1.0m to €1.5m
Indication €593,062 to €802,316

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€139,852
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€139,852

Capitalised earnings

net result for the year (9904)
2025
€160,527
2024
€146,415
2023
€134,227
excluding non-recurring income and charges
€132,491
2022
€144,644
excluding non-recurring income and charges
€144,309
2021
€132,918
excluding non-recurring income and charges
€133,161
Average result, excluding non-recurring income and charges
€146,478
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.0m / €1.2m / €1.5m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 17 November 2026 via checked.be.